Viewing Study NCT03488251


Ignite Creation Date: 2025-12-24 @ 11:49 PM
Ignite Modification Date: 2026-01-06 @ 2:13 AM
Study NCT ID: NCT03488251
Status: TERMINATED
Last Update Posted: 2022-08-16
First Post: 2018-03-12
Is NOT Gene Therapy: True
Has Adverse Events: True

Brief Title: PK,PD,Safety and Tolerability of Multiple Dose Regimens of MT-3724 With Gemcitabine and Oxaliplatin for the Treatment of Patients With Relapsed/Refractory Diffuse Large B Cell Non-Hodgkin's Lymphoma
Sponsor:
Organization: